title: Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
authors.affiliation: Department of Surgery, Henry Ford Hospital, Detroit, Michigan 48202.
authors.forename: Y
authors.initials: Y
authors.lastname: Wiener
authors.forename: R E
authors.initials: RE
authors.lastname: Nakhleh
authors.forename: W L
authors.initials: WL
authors.lastname: Kupin
authors.forename: M
authors.initials: M
authors.lastname: Lee
authors.forename: F S
authors.initials: FS
authors.lastname: Escobar
authors.forename: K K
authors.initials: KK
authors.lastname: Venkat
authors.forename: M F
authors.initials: MF
authors.lastname: Mozes
mesh_terms: D000704:Analysis of Variance; D001707:Biopsy, Needle; D004351:Drug Resistance; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012044:Regression Analysis; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D016853:Muromonab-CD3; D013256:Steroids